Overall rank by patents
#2,185
of 49,997 tracked assignees
USPTO PatentsView assignee record - 180 granted patents across 38 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Olympus ranks #2,185 of 49,997 tracked US assignees by granted-patent volume, with 180 patents across 38 technology areas.
USPTO PatentsView assignee plate
Corpus R2185 · Foreign Corporation #2,185 · 180 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-STRONG · CLAIMS-PAR · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: Delavan Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Polaris Industries · near
67 score
Gree Electric… · near
67 score
Olympus Medical… · this assignee
67 score
University of Rhode… · near
67 score
THE Trustees OF… · near
67 score
3D Lighting… · lowest
7 score
What this shows Olympus's Innovation Score is 66.6/100 (top 1% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Olympus Medical Systems Corporation is a focused PatentsView assignee: 38 CPC subclasses with 93.3% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2015 (109 grants) versus a trough of 8 in 2023. By volume, Olympus sits between Delavan Inc. and Ansaldo Energia Switzerland AG.
Olympus Medical Systems Corporation shows 33 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Delavan Inc.
180 patents
GIESECKE+DEVRIENT Currency Technology GMBH
180 patents
Maplebear Inc.
180 patents
Nipro Corporation
180 patents
Samtec, Inc.
180 patents
Stmicroelectronics PTE Ltd
180 patents
Sumitomo Seika Chemicals Co., Ltd.
180 patents
Olympus Medical Systems Corporation
180 patents
Ansaldo Energia Switzerland AG
179 patents
What this shows Olympus holds 180 patents at rank #2,185, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #2,185 in granted patent volume.
Other assignees with the most granted patents in Olympus's primary technology class.
Two PlainPatent-derived peer sets for Olympus, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (67 here).
Nearest assignees by average claims per patent (11.4 here).
Olympus's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
67 Top 1% higher than 99% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 109 | 60.6% |
| 2023 | 8 | 4.4% |
| 2024 | 25 | 13.9% |
| 2025partial year | 38 | 21.1% |
Top 15 of 38 technology areas
Overall rank by patents
#2,185
of 49,997 tracked assignees
66.6 out of 100
What to do with this data
Olympus Medical Systems Corporation's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.